Admedus Tweet
"Admedus Immunotherapies received $250,000 in Ignite Ideas funding to carry out a clinical trial which is due to be completed by early 2019"
- Forums
- ASX - By Stock
- Ahz vax in news
Admedus Tweet "Admedus Immunotherapies received $250,000 in...
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.61 |
Change
-0.300(3.03%) |
Mkt cap ! $202.9M |
Open | High | Low | Value | Volume |
$9.50 | $9.61 | $9.31 | $95.67K | 10.07K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 34 | $9.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.67 | 923 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 34 | 9.500 |
1 | 785 | 9.410 |
1 | 99 | 9.310 |
1 | 2000 | 9.300 |
2 | 412 | 9.200 |
Price($) | Vol. | No. |
---|---|---|
9.670 | 923 | 6 |
9.680 | 161 | 1 |
9.690 | 180 | 1 |
9.700 | 180 | 1 |
9.910 | 13 | 1 |
Last trade - 12.38pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online